Clene Inc. secures additional NIH grant funds for ALS therapy
Go back to Clene Inc. secures additional NIH grant funds for ALS therapy| (NASDAQ: CLNN) | Delayed: 3.94 +0.10 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.84 | 52 Week High | $ | |||
| Open | $3.84 | 52 Week Low | $ | |||
| Day High | $3.97 | P/E | N/A | |||
| Day Low | $3.84 | EPS | $ | |||
| Volume | 8,226 | |||||



